Piramal Enterprises Limited (PEL.NS)
INR 978.0
(1.04%)
INR 978.0
(1.04%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 8.04 Billion INR | -83.13% |
| 2022 | 47.67 Billion INR | -56.63% |
| 2021 | 109.92 Billion INR | 20.61% |
| 2020 | 91.14 Billion INR | -17.76% |
| 2019 | 110.83 Billion INR | -2.76% |
| 2018 | 113.98 Billion INR | 28.43% |
| 2017 | 88.74 Billion INR | 28.77% |
| 2016 | 68.91 Billion INR | 35.0% |
| 2015 | 51.05 Billion INR | 39.26% |
| 2014 | 36.66 Billion INR | 14.21% |
| 2013 | 32.09 Billion INR | 36.94% |
| 2012 | 23.43 Billion INR | 111.25% |
| 2011 | 11.09 Billion INR | -24.42% |
| 2010 | 14.68 Billion INR | -33.34% |
| 2009 | 22.02 Billion INR | 12.04% |
| 2008 | 19.65 Billion INR | 11.33% |
| 2007 | 17.65 Billion INR | 16.14% |
| 2006 | 15.2 Billion INR | 53.17% |
| 2005 | 9.92 Billion INR | 45.17% |
| 2004 | 6.83 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 17.56 Billion INR | 483.7% |
| 2024 Q1 | 3 Billion INR | 126.61% |
| 2023 Q1 | 15.84 Billion INR | 787.98% |
| 2023 FY | 8.04 Billion INR | -83.13% |
| 2023 Q3 | 17.4 Billion INR | 11.57% |
| 2023 Q2 | 15.6 Billion INR | -1.57% |
| 2023 Q4 | -11.31 Billion INR | -164.98% |
| 2022 Q3 | 20.79 Billion INR | 10.55% |
| 2022 FY | 47.67 Billion INR | -56.63% |
| 2022 Q1 | 30.44 Billion INR | 6.7% |
| 2022 Q2 | 18.81 Billion INR | -38.21% |
| 2022 Q4 | 1.78 Billion INR | -91.42% |
| 2021 FY | 109.92 Billion INR | 20.61% |
| 2021 Q3 | 32.27 Billion INR | 30.37% |
| 2021 Q1 | 24.36 Billion INR | 161.91% |
| 2021 Q4 | 28.53 Billion INR | -11.6% |
| 2021 Q2 | 24.75 Billion INR | 1.61% |
| 2020 Q4 | 9.3 Billion INR | -65.43% |
| 2020 FY | 91.14 Billion INR | -17.76% |
| 2020 Q1 | 26.34 Billion INR | 102.95% |
| 2020 Q2 | 28.59 Billion INR | 8.54% |
| 2020 Q3 | 26.9 Billion INR | -5.89% |
| 2019 Q3 | 34.35 Billion INR | 8.57% |
| 2019 FY | 110.83 Billion INR | -2.76% |
| 2019 Q2 | 31.64 Billion INR | -0.41% |
| 2019 Q4 | 12.97 Billion INR | -62.22% |
| 2019 Q1 | 31.77 Billion INR | 10.31% |
| 2018 FY | 113.98 Billion INR | 28.43% |
| 2018 Q2 | 28.07 Billion INR | 9.18% |
| 2018 Q1 | 25.71 Billion INR | 3.8% |
| 2018 Q4 | 28.8 Billion INR | -8.27% |
| 2018 Q3 | 31.39 Billion INR | 11.85% |
| 2017 FY | 88.74 Billion INR | 28.77% |
| 2017 Q4 | 24.76 Billion INR | -1.96% |
| 2017 Q3 | 25.26 Billion INR | 17.12% |
| 2017 Q2 | 21.57 Billion INR | 10.47% |
| 2017 Q1 | 19.52 Billion INR | -2.53% |
| 2016 FY | 68.91 Billion INR | 35.0% |
| 2016 Q4 | 20.03 Billion INR | 2.61% |
| 2016 Q3 | 19.52 Billion INR | 20.42% |
| 2016 Q2 | 16.21 Billion INR | 11.61% |
| 2016 Q1 | 14.52 Billion INR | 11.0% |
| 2015 Q4 | 13.08 Billion INR | -11.55% |
| 2015 Q1 | 11.42 Billion INR | 36.02% |
| 2015 Q2 | 12.62 Billion INR | 10.52% |
| 2015 Q3 | 14.79 Billion INR | 17.2% |
| 2015 FY | 51.05 Billion INR | 39.26% |
| 2014 Q1 | 8.62 Billion INR | 16.39% |
| 2014 Q4 | 8.39 Billion INR | -20.43% |
| 2014 Q2 | 8.95 Billion INR | 3.89% |
| 2014 FY | 36.66 Billion INR | 14.21% |
| 2014 Q3 | 10.55 Billion INR | 17.86% |
| 2013 Q1 | 7.23 Billion INR | 24.46% |
| 2013 FY | 32.09 Billion INR | 36.94% |
| 2013 Q4 | 7.4 Billion INR | -21.18% |
| 2013 Q3 | 9.39 Billion INR | 16.56% |
| 2013 Q2 | 8.06 Billion INR | 11.46% |
| 2012 Q4 | 5.81 Billion INR | -17.83% |
| 2012 Q2 | 5.94 Billion INR | 28.77% |
| 2012 Q1 | 4.61 Billion INR | 69.48% |
| 2012 Q3 | 7.07 Billion INR | 19.04% |
| 2012 FY | 23.43 Billion INR | 111.25% |
| 2011 Q3 | 3.24 Billion INR | 0.0% |
| 2011 FY | 11.09 Billion INR | -24.42% |
| 2011 Q4 | 2.72 Billion INR | -16.1% |
| 2010 FY | 14.68 Billion INR | -33.34% |
| 2009 FY | 22.02 Billion INR | 12.04% |
| 2008 FY | 19.65 Billion INR | 11.33% |
| 2007 FY | 17.65 Billion INR | 16.14% |
| 2006 FY | 15.2 Billion INR | 53.17% |
| 2005 FY | 9.92 Billion INR | 45.17% |
| 2004 FY | 6.83 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Amrutanjan Health Care Limited | 2.09 Billion INR | -284.105% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -64015.584% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 12.635% |
| FDC Limited | 6.58 Billion INR | -22.123% |
| Gufic Biosciences Limited | 4.07 Billion INR | -97.443% |
| Hikal Limited | 5.95 Billion INR | -35.0% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -94.601% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -70.441% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -1196.309% |
| Medico Remedies Limited | 262.14 Million INR | -2968.275% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -66.76% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -1420.082% |
| RPG Life Sciences Limited | 2.48 Billion INR | -223.935% |
| Sequent Scientific Limited | 2.97 Billion INR | -170.024% |
| Shilpa Medicare Limited | 3.56 Billion INR | -125.815% |
| Sigachi Industries Limited | 2 Billion INR | -301.706% |
| Themis Medicare Limited | 2.42 Billion INR | -232.367% |
| Unichem Laboratories Limited | 4.86 Billion INR | -65.332% |
| Venus Remedies Limited | 2.18 Billion INR | -268.522% |
| Wanbury Limited | 1.73 Billion INR | -364.758% |
| ZIM Laboratories Limited | 1.26 Billion INR | -534.423% |
| Lupin Limited | 125.09 Billion INR | 93.57% |
| Innova Captab Limited | 3.46 Billion INR | -132.167% |
| Ind-Swift Limited | 2.17 Billion INR | -270.227% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -446.492% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 92.657% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 585.736% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -29.257% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -1063.684% |
| Morepen Laboratories Limited | 6.16 Billion INR | -30.546% |
| Laurus Labs Limited | 15.44 Billion INR | 47.935% |
| Aarti Drugs Limited | 8.31 Billion INR | 3.282% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 35.307% |
| Alembic Limited | 1 Billion INR | -704.244% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 69.966% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 88.4% |
| Vaishali Pharma Limited | 90.32 Million INR | -8805.041% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -37.932% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -1132.52% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 59.053% |
| Eris Lifesciences Limited | 10.42 Billion INR | 22.859% |
| Windlas Biotech Limited | 1.33 Billion INR | -500.784% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 96.888% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -326.278% |
| Orchid Pharma Limited | 2.32 Billion INR | -246.649% |
| Albert David Limited | 1.4 Billion INR | -471.222% |
| Hester Biosciences Limited | 1.27 Billion INR | -531.516% |
| Sakar Healthcare Limited | 699.58 Million INR | -1049.724% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -95.071% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -39.124% |
| Divi's Laboratories Limited | 32.44 Billion INR | 75.206% |
| Mankind Pharma Limited | 42.19 Billion INR | 80.939% |
| Neuland Laboratories Limited | 8.24 Billion INR | 2.48% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 47.288% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 93.576% |
| Wockhardt Limited | 7.72 Billion INR | -4.188% |
| Bal Pharma Limited | 770.19 Million INR | -944.32% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 95.084% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -117.655% |
| Alkem Laboratories Limited | 52.29 Billion INR | 84.62% |
| Valiant Laboratories Limited | 138.02 Million INR | -5727.254% |
| Ajanta Pharma Limited | 21.06 Billion INR | 61.815% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -1678.889% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -7016.138% |
| Granules India Limited | 16.79 Billion INR | 52.121% |
| Medicamen Biotech Limited | 495.49 Million INR | -1523.286% |
| Ipca Laboratories Limited | 48.58 Billion INR | 83.445% |
| Brooks Laboratories Limited | 65.62 Million INR | -12157.391% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -1337.579% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 82.798% |
| NATCO Pharma Limited | 25.73 Billion INR | 68.747% |
| Suven Life Sciences Limited | -200.79 Million INR | 4105.687% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 7496.342% |
| Strides Pharma Science Limited | 14.38 Billion INR | 44.098% |
| Indoco Remedies Limited | 8.04 Billion INR | -0.004% |
| Alpa Laboratories Limited | 188.89 Million INR | -4158.08% |
| Lasa Supergenerics Limited | 121.02 Million INR | -6545.708% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -1956.763% |